How to switch from Lantus (insulin glargine) 20 units twice a day to NPH (Neutral Protamine Hagedorn) insulin twice a day?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 25, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Switching from Lantus 20 Units Twice Daily to NPH Twice Daily

When converting from Lantus (insulin glargine) 20 units twice daily (total 40 units/day) to NPH twice daily, use 80% of the total Lantus dose as your starting NPH dose, which equals 32 units total NPH per day, split as approximately 21 units before breakfast and 11 units before dinner (2/3 morning, 1/3 evening). 1

Conversion Algorithm

Step 1: Calculate Total NPH Dose

  • Current total daily Lantus dose: 40 units (20 units × 2)
  • Starting NPH dose: 32 units total (80% of 40 units) 1, 2, 1
  • This dose reduction accounts for the different pharmacokinetic profiles and helps prevent hypoglycemia during the transition 2, 1

Step 2: Split the NPH Dose

  • Morning dose (before breakfast): 21 units (2/3 of total) 1
  • Evening dose (before dinner): 11 units (1/3 of total) 1
  • This distribution pattern aligns with typical insulin requirements and NPH's intermediate-acting profile 2, 1

Step 3: Titration Protocol

  • Monitor fasting plasma glucose to assess adequacy of the evening NPH dose 1
  • Increase dose by 2 units every 3 days if glucose remains above target without hypoglycemia 1
  • For hypoglycemia: Determine the cause; if no clear reason exists, lower the corresponding dose by 10-20% 1, 2, 1

Critical Monitoring Parameters

Blood Glucose Targets

  • Check fasting glucose to adjust evening NPH dose 1
  • Check pre-dinner glucose to adjust morning NPH dose 1
  • Monitor for nocturnal hypoglycemia, which is more common with NPH than with Lantus 3, 4

Hypoglycemia Risk

  • NPH carries significantly higher risk of hypoglycemia compared to Lantus, particularly nocturnal episodes (26-59% increased risk) 4
  • The intermediate-acting profile of NPH creates a pronounced peak at 4-6 hours post-injection, unlike Lantus's flat profile 3, 4
  • Patients should be counseled about this increased risk and prescribed glucagon for emergencies 1

Important Clinical Considerations

Why This Conversion May Be Necessary

  • Cost considerations: NPH is significantly less expensive than Lantus 1
  • The American Diabetes Association guidelines acknowledge NPH as an appropriate basal insulin option when cost is a barrier 1

Common Pitfalls to Avoid

  • Do not convert unit-for-unit: Always use the 80% reduction to prevent hypoglycemia during transition 1, 2, 1
  • Do not give NPH at bedtime initially: The 2/3 morning, 1/3 evening split is preferred for twice-daily regimens 1
  • Do not delay dose adjustments: Reassess every 3 days and titrate based on glucose patterns 1

When to Reconsider This Switch

  • If the patient develops recurrent hypoglycemia despite dose adjustments, consider switching back to a basal analog 1
  • If the patient frequently forgets evening doses, morning-only long-acting basal insulin would be more appropriate 1
  • Patients with hypoglycemia unawareness are poor candidates for NPH due to its peaked action 1, 4

Additional Therapy Considerations

  • If the patient is not already on a GLP-1 receptor agonist, consider adding one to reduce insulin requirements and hypoglycemia risk 1
  • If prandial coverage is needed, NPH can be mixed with short- or rapid-acting insulin to reduce injection burden 1

Related Questions

What should the Lantus (insulin glargine) dose be for a patient with type 1 diabetes who has undergone a pancreas transplant and is currently NPO (nothing by mouth)?
What is the appropriate Lantus (insulin glargine) dose reduction for an 84-year-old male with type 2 diabetes, weight 74 kg, and BMI 25, who will be NPO at midnight?
How to manage type 1 diabetes in an underweight patient with well-controlled overnight glucose on Lantus (insulin glargine)?
How to adjust Lantus (insulin glargine) dose for a patient with Type 2 diabetes and hyperglycemia?
What is the recommended increase in Lantus (insulin glargine) dose for a patient with hyperglycemia, who previously used an insulin pump with basal needs ranging from 19-29 units, and is now taking 10 units of Lantus with a fasting blood glucose level of 220 and overnight blood glucose level of 179?
What is the preferred corticosteroid, hydrocortisone (cortisol) or methylprednisolone, for managing adrenal crisis?
What are the recommendations for post-operative X-ray (X-ray) imaging after total hip replacement?
What is the appropriate Meropenem dose for a patient with a GFR of 25?
Is nicotinamide safe for patients with coronary artery disease (CAD) to use for solar keratosis and skin cancer prevention?
Will radial artery occlusion (blockage) symptoms of pain, numbness, and tingling resolve on their own a month after angiogram?
Is there a benefit to starting steroid therapy in a patient with a diffuse rash following a positive streptococcal (strep) test?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.